Drug major Dr Reddy’s Laboratories on Friday said it has received shareholders nod for proposed amalgamation of Dr Reddy’s Holdings Ltd into the company. The resolution for the scheme was approved by 99.98...
Mankind Pharma inks pact with Glenmark for anti-diabetes drug
Mankind Pharmaceuticals Ltd and Glenmark Pharmaceuticals Ltd today inked a sub-licensing agreement to co-market anti-diabetes drug remogliflozin etabonate in India. Under the agreement, Mankind Pharma will market...
Roche dives deeper into gene therapy with $1.15 billion Sarepta licensing deal
Roche Holding AG made its second major gene therapy deal in a year on Monday, spending $1.15 billion to obtain the rights to Sarepta Therapeutics Inc’s investigational drug to treat Duchenne muscular dystrophy (DMD)...
Roche to complete $4.3 bn acquisition of Spark as regulators give all clear
Swiss drugmaker Roche plans to complete its $4.3 billion takeover of gene therapy specialist Spark Therapeutics on Tuesday after U.S. and British authorities ruled the deal would not hurt competition in hemophilia A...
Cipla acquires brand, trademark for anti-diabetic drug Vysov in India
Homegrown pharma major Cipla Ltd on Monday said it has acquired brand name and trademark rights for Vysov for anti-diabetic drug Vildagliptin for the Indian market from Novartis. However, it didn’t disclose the...
U.S. approves Roche’s $4.3 billion purchase of Spark Therapeutics
Swiss drugmaker Roche has won U.S. antitrust approval for its $4.3 billion deal to buy gene therapy specialist Spark Therapeutics clearing the way for Roche’s push into treating rare diseases including hemophilia A. The...
France’s Sanofi to buy Synthorx for $2.5 bln
France’s Sanofi said on Monday it had agreed to buy Synthorx in a cash deal worth around $2.5 billion as it seeks to beef up its immuno-oncology pipeline. Under the terms of the merger agreement, Sanofi has...
SC orders interim stay on NCLAT order on Orchid Pharma resolution process
The Supreme Court has ordered an interim stay on the National Company Law Appellate Tribunal’s (NCLAT’s) ruling on the resolution of debt-ridden Orchid Pharma. The NCLAT in November set aside the National Company Law...
USV in talks with Novartis to buy Jalra Trademark for Rs. 200 Crore
Mumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal valued at more than Rs. 200 crore, people aware of the development told ET. The...
Mankind Pharma eyes acquisition of biotech firms, plans new launches
Mankind Pharma is actively looking for buyouts in the biotechnology space after talks with Bharat Serums and Vaccines fell through. The company feels that a manufacturing site would be crucial for...
Mankind Pharma eyes acquisition of biotech firms, plans new launches
Mankind Pharma is actively looking for buyouts in the biotechnology space after talks with Bharat Serums and Vaccines fell through. The company feels that a manufacturing site would be crucial for...
Eris Lifesciences acquires trademark Zomelis from Novartis AG for $13 mn
Eris Lifesciences on Tuesday announced acquisition of the trademark Zomelis, for Vildagliptin-based formulations, and its associated trademarks from Novartis AG, Switzerland, for a consideration of $13 million (roughly...
